Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)
Clinical trial NCT05231668 · TERMINATED
Trial details
- NCT number
- NCT05231668
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-25
- Primary completion
- 2024-11-12
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.